Prevalence of HIV, hepatitis B, C and G virus infections among injecting drug users on methadone maintenance treatment in Maribor

被引:0
作者
Baklan, Z
Gorisek, JR
Poljak, M
Pisec, A
机构
[1] Maribor Teaching Hosp, Dept Infect Dis, SLO-2000 Maribor, Slovenia
[2] Fac Med, Inst Microbiol & Immunol, Ljubljana, Slovenia
[3] Primary Hlth Care Ctr Maribor, Maribor, Slovenia
关键词
HIV; hepatitis; injecting drug users; methadone;
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The prevalence of human immunodeficiency virus (HIV) infection and hepatitis B, C, and G virus infections was determined in a selected group of 40 intravenous drug addicts on methadone maintenance treatment. No drug addict was infected with HIV. Seven drug addicts (17.5%) had serologic markers of hepatitis B infection but only one among them (2.5%) exhibited signs of active infection. 16 drug addicts (40%) had serologic markers of hepatitis C infection and 13 (32.5%) of them had an active infection with positive viral tests. 22 addicts (55%) had signs of hepatitis G infection, 9 (22.5%) of them had signs of active infection and 13 (32.5%) had signs of past infection. Addicts infected with the hepatitis B and C viruses were older and had also been taking drugs longer than those who were not infected with these two viruses. The proportion of those susceptible to infection with hepatitis B (70%) is high, reflecting a low prevalence of this disease and at the same time revealing the failure of preventive measures and the unacceptably low vaccination rate.
引用
收藏
页码:5 / 7
页数:3
相关论文
共 22 条
  • [1] [Anonymous], 1998, JAMA, V280, P1936
  • [2] DEKLEVA B, 1998, DROGE MED SREDNJESOL
  • [3] FLAKER V, 1999, SOCIALNO DELO, V38, P341
  • [4] Viral infections in short-term injection drug users: The prevalence of the hepatitis C, hepatitis B, human immunodeficiency, and human T-lymphotropic viruses
    Garfein, RS
    Vlahov, D
    Galai, N
    Doherty, MC
    Nelson, KE
    [J]. AMERICAN JOURNAL OF PUBLIC HEALTH, 1996, 86 (05) : 655 - 661
  • [5] Hagan H, 2000, MT SINAI J MED, V67, P423
  • [6] Hagan H, 2001, AM J PUBLIC HEALTH, V91, P42, DOI 10.2105/AJPH.91.1.42
  • [7] Lamagni T L, 1999, Commun Dis Public Health, V2, P174
  • [8] EPIDEMIOLOGY OF HEPATITIS-B VIRUS-INFECTIONS AMONG INJECTING DRUG-USERS - SEROPREVALENCE, RISK-FACTORS, AND VIRAL INTERACTIONS
    LEVINE, OS
    VLAHOV, D
    NELSON, KE
    [J]. EPIDEMIOLOGIC REVIEWS, 1994, 16 (02) : 418 - 436
  • [9] Seroprevalence of hepatitis C markers among intravenous drug users in western European countries:: a systematic review
    Matheï, C
    Buntinx, F
    Damme, PV
    [J]. JOURNAL OF VIRAL HEPATITIS, 2002, 9 (03) : 157 - 173
  • [10] Response to HBV vaccine in relation to anti-HCV and anti-HBc positivity: a study in intravenous drug addicts
    Minniti, F
    Baldo, V
    Trivello, R
    Bricolo, R
    Di Furia, L
    Renzulli, G
    Chiaramonte, M
    [J]. VACCINE, 1999, 17 (23-24) : 3083 - 3085